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The assembly includes a hydrogel cartridge for containing one or more nude isolated blastomeres which can
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[57] ABSTRACT 
An arti?cial zona pellucida is provided for implantation 
in the peritoneal cavities of small laboratory animals. 
The assembly includes a hydrogel cartridge for contain 
ing one or more nude isolated blastomeres which can be 
cultured therein to an implant stage in the peritoneal 
cavity of a small animal such as a mouse. The combina 
tion is particularly advantageous for culturing of nude 
isolated blastomeres of a species different from the host 
small laboratory animal, such as blastomeres of domes 
tic animals. 
12 Claims, 2 Drawing Sheets 
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ARTIFICIAL ZONA PELLUCIDA FOR IN VIVO 
CULTURE OF NUDE BLASTOMERES 
FIELD OF INVENTION 
The ?eld of this invention is mammalian embryo 
culture, and, in particular, the culturing of separated 
embryo cells to a stage at which they can be implanted. 
BACKGROUND OF INVENTION 
Although it is known that individual cells (blas 
tomeres) of a developing mammalian embryo prior to 
the blastocyst implant stage are capable of developing 
into totipotent embryos, manipulation of embryos in the 
2-, 4-, or 8-cell morulae stage has met with limited ex 
perimental success and has not developed into a com 
mercial practice. Moore, et al. (1968) reported on a 
series of experiments with rabbit ova in which individ 
ual blastomeres were cultured in their own ova mem 
brane (the zona pellucida). The culturing was compared 
with that of nude blastomeres without zona, and sepa 
rated blastomeres inserted in the host zona. The cultur 
ing of the blastomeres was carried out in the fallopian 
tubes of the recipient does. No single blastomere devoid 
of zona survived, but survival was obtained with some 
of the blastomeres separated from the 2-, 4-, and 8-cell 
ova enclosed in their own zona, and the surviving blas 
tomeres developed into normal rabbits. Separation of 
the blastomeres at the 2.cell stage gave a higher rate of 
survival (30%) than those separated at the 4- and 8-cell 
eggs (19% and 11%). Single blastomeres of 4-cell ova 
inserted in host zona showed limited development, un 
dergoing one or more cleavages. 
Isolated blastomeres and blastomere clusters pre 
pared by microsurgery from pre-implantation embryos 
require some form of protection when the zona pellu 
cida is removed or its integrity compromised (Moore, et 
al., 1968; Willadsen, 1979). Agar has been used to seal or 
encapsulate ruptured zona pellucida containing blas 
tomeres (Willadsen, 1979). In the experiments reported 
by Willadsen, 2-celled sheep embryo were manipulated 
by severing the zona pellucida, removing and separat 
ing the blastomeres, and re-inserting a single blastomere 
into an evacuated zona. The zona-containing blas 
tomeres were transferred to an agar solution held in the 
tip of a pipette until the solution hardened. A tiny solid 
cylinder of the agar containing the zona~encased blasto 
mere was ejected. The small cylinders were encapsu 
lated in larger solid cylinders of agar. The cylinders 
were transferred to ewe oviducts for incubation. After 
reaching the late morulae or early blastocyst stage, the 
agar cylinders were recovered, the agar was removed, 
and the embryos were implanted. Some live offspring 
were produced. The reduced embryo survival rate 
compared to standard embryo transfer was attributed to 
the difficulty of manipulating the embryos in the agar, 
which required the use of hypodermic needles, and 
other procedures. 
The embedding of embryos in agar is referred to in 
the literature as the agar “chip” technique. The micro 
manipulations involved in the agar chip technique were 
summarized by Willadsen in 1982 in a treatise on “Mam~ 
malian Egg Transfer”. After referring to the disappoint 
ing results in experiments on the developmental poten 
tial of isolated blastmeres, Willadsen concluded “with 
near certainty that the central problem in all instances 
arose from the lack of adequate methods for culture of 
the micromanipulated embryos in vitro in line with the 
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inability of the embryonic cells to survive in vivo after 
the zona pellucida had been ruptured or removed”. He 
further concluded that “none of the methods currently 
used is entirely satisfactory for the culture of early em 
bryos, i.e., cleavage stages which are most dependent 
on the zona pellucida for their survival in vivo.” 
With reference to agar embedding, Willadsen (1982) 
had reported that “single blastomeres may be embedded 
without a zona pellucida, but this is not advisable, be 
cause it makes it very difficult to release the embryos at 
a later stage”. Willadsen recommended that isolated 
blastomeres be contained in their own zona or in host 
zona, and that agar chip embedding be used only for 
such zona-contained blastomeres. 
Egestone et al. (1985) reported on experiments in 
which l-cell bovine embryos were embedded in agar 
and successfully cultured to the blastocyst stage in ewe 
oviducts. A tendency of the chips to dissolve in the 
oviduct ?uid was observed. Boland (1984) reported on 
experiments using the rabbit oviduct as a screening tool 
for the viability of mammalian eggs embedded in agar 
chips. He concluded that the rabbit oviducts were un 
suitable for such screening "because of the high rate of 
degradation of agar chips”. More recently, Adaniya, et 
al. (1987) reported on the coating of rabbit embryos 
ready for implantation with sodium alginate. Following 
implantation in the uterus, the rate of degradation of the 
sodium alginate was observed. It was found that after 
four hours only 38% of the capsules remained, and after 
six hours none of the capsules were recoverable. 
SUMMARY OF INVENTION 
The present invention provides an artificial zone 
pellucida which can be used for culturing of isolated 
mammalian blastomeres, or blastomere clusters, with 
out the use of any natural zona pellucida. The nude 
blastomeres are inserted directly in the arti?cial zona 
pellucida, which comprises a hollow cartridge of a size 
suitable for implantation in the peritoneal cavity or 
fallopian tube of a host mammal. The cartridge provides 
an enclosed incubation chamber having a chamber 
enclosing wall formed of a cross-linked microporous 
hydrogel which is essentially non-biodegradeable. At 
least one viable nude mammalian blastomere is remov 
ably contained in the incubation chamber, and an aque 
ous culture medium is contained in the chamber in 
contact with the blastomere and the inside of the hydro 
gel wall. After implantation, transfer of substances from 
the fallopian or peritoneal ?uid can take place through 
the hydrogel wall, thereby promoting the development 
of the blastomere to the blastocyst stage, ready for 
recovery and implantation. 
For convenient insertion and removal of the blas 
tomeres, the arti?cial zona pellucida cartridges can be 
provided with removable end plugs. If it is desired to 
culture more than one blastomere in the same cartridge, 
dividers may be provided within the cartridge separat 
ing the interior of the cartridge into a series of separate 
compartments. The dividers may also be made remov 
able for convenient insertion and recovery of the em 
bryos. 
A preferred hydrogel material is a cross-linked meth 
acrylate polymer, such as- the hydrogel known as 
HEMA. HEMA consists primarily of polymerized 2 
hydroxyethyl methacrylate. HEMA polymers may be 
cross-linked with glycol dimethacrylates, such as ethyl 
ene glycol dimethacrylate or tetraethylene glycol di 
5,272,086 3 
methacrylate. For purpose of the present invention, the 
cross-linking should not be so extensive that it prevents 
the hydrogel from functioning as a microporous mem 
brane. In general, the amount of cross-linker employed 
should not be over 2.5 mole percent of the hydrogel. 
THE DRAWINGS 
Arti?cial zona pellucida assemblies constructed in 
accordance with the present invention are illustrated by 
the accompanying drawings, in which 
FIG. 1 is an exploded perspective view of a hydrogel 
cartridge; 
FIG. 2 is a side elevational view of the assembled 
cartridge of FIG. 1 containing a blastomere in an aque 
ous medium; 
FIG. 3 is a sectional view of a modi?ed hydrogel 
cartridge assembly including removable dividers which 
separate the cartridge chamber into a plurality of com 
partments receiving individual nude blastomeres; 
FIG. 4 is a diagrammatic view of a mouse with a 
portion of the mouse abdomen broken away to illustrate 
the insertion in the peritoneal cavity of the arti?cial 
zona pellucida assembly of this invention; 
FIG. 5 is a sectional side elevational view of a modi 
?ed hydrogel cartridge assembly which can be used for 
ova fertilization, including two chambers separated by a 
perforated divider, one for containing sperm and the 
other the ova to be fertilized; and . 
FIG. 6 is a view similar to FIG. 2, but illustrating use 
of the cartridge assembly as an incubator for a fertilized 
ova. 
DETAILED DESCRIPTION 
The arti?cial zona pellucida assembly of this inven 
tion can be employed for a number of different micro 
manipulations and culturings of mammalian embryos. 
In a preferred application, the assembly is employed for 
in vivo culturing of nude blastomeres, or clusters of 
nude blastomeres. For example, mammalian embryos in 
the morulae stage prior to blastulation can be separated 
by microsurgical techniques into individual blas 
tomeres. Use of blastomeres derived from 2-, 4-, or 
8-cell embryos can provide the means for the use of 
chimaeric production of multiple viable, totipotent em 
bryos from a single fertilized ova. The techniques for 
separation and recovery of the blastomeres can be the 
same as previously employed. (See, for example, Wil 
ladsen, 1984.) Instead of individual nude blastomeres, 
clusters of two or four blastomeres can be used. For 
example, a 4-cell embryo can be separated into two-cell 
clusters. 
For purpose of the present invention, the assembly 
comprising the arti?cial zona pellucida includes a hol 
low cartridge of a size suitable for implantation in a 
peritoneal cavity or fallopian tube of a host mammal. 
Where small mammals are to be employed, such as mice 
or rabbits, as may be preferred, the dimensions of the 
cartridge should be quite small, that is, the length may 
be from 1 to 3 cm and the exterior diameter from 3 to 5 
mm. To achieve effective culture of the nude blasto 
mere to the blastocyst stage, it is important that the 
body of the cartridge be formed from a microporous 
hydrogel. 
Polymers of alkyl acrylates are known to form hydro 
gels which can be cross-linked to provide microporous 
structures. A preferred monomer for forming the hy 
drogel is Z-hydroxyethyl methacrylate (HEMA). 
HEMA can be polymerized in the presence of glycol 
20 
25 
30 
35 
40 
45 
55 
60 
65 
4 
dimethacrylate monomers which function as cross-link 
ers. Preferred cross-linkers are ethylene glycol dirneth 
acrylate or tetraethylene glycol dimethacrylate. A lim 
ited degree of cross-linking is desirable. The swollen or 
hydrated membranes of cross-linked pI-IEMA should 
function essentially as pore-type membranes. They 
should also be essentially non-biodegradeable under the 
conditions of use. Solute transport should take place 
through water-?lled regions of the hydrogel, which 
acts as the pores. At high cross-linking levels, the hy 
drogel membrane begins to function as a partition-type 
membrane. The solute interacts with the membrane 
matrix and diffusion is retarded. See Wisniewski, et al. 
(1976). 
Data presented by Wisniewski indicated that cross 
linked HEMA membranes up to about 2.5 mole % 
cross-linker can function essentially as microporous or 
pore-type membranes. For the purpose of this inven 
tion, it is therefore preferred that the hydrogel contain 
not over 2.5 mole percent of cross-linker, such as from 
0.1 to 2.5 mole %. A preferred cross-linker range is 
from 0.2 to 1.0 mole percent in the hydrogel. Such 
exhibit high diffusivities as shown by Lee, et al., 1978). 
An optimum formulation is from 0.3 to 0.5 mole % of a 
glycol dimethacrylate cross-linker. 
Procedures for preparing the cross-linked polymer 
ized hydrogels are known. A mixture of the HEMA 
monomer and the cross-linker is prepared in the desired 
proportions using a suitable solvent such as ethylene 
glycol, or a mixture of ethylene glycol and water. Initia 
tor solutions are also prepared, such as an aqueous solu 
tion of ammonium persulfate, and an aqueous solution 
of sodium metabisul?te. These reactants are combined 
under pressure to minimize the entrapment of bubbles in 
the hydrogel. A suitable pressure casting procedure 
using two hypodermic syringes is described in Pinchuk 
et a1. (1981), and this procedure is also described in the 
following experimental examples. 
It was found that the nude blastomeres could be 
loaded into the arti?cial zona pellucida tube using only 
sterile normal saline as the medium. This evidences that 
transfer of substances from the peritoneal or fallopian 
tube ?uid, takes place and promotes blastomere devel 
opment. It is preferred to use a starting medium which 
contains nutrients known to promote the growth of 
embryos or blastomeres. Whitten’s medium (Whitten et 
al., 1968) supplemented with bovine serum albumin 
(BSA) can be used. Other suitable media for culturing 
embryos or blastomeres are described by Fisher (1987), 
Camous et al. (1984), and Brinster (1984). These include 
(suggest describing one or two suitable media. 
The body cavity, referred to as the peritoneal cavity, 
is a suitable site for implantation of the arti?cial zona 
pellucida assembly in the host animal. For small labora 
tory animals, such as mice, hamsters, rabbits, etc., this is 
a more convenient site than the fallopian tubes. For 
implants in larger animals, such as sheep (ewes), the 
fallopian tubes can be used, and may be employed in 
ligated form. Means may be provided surgically for 
convenient insertion and removal in fallopian tubes. 
The ?uid present in the peritoneal cavity of female 
mammals is similar to that found in its fallopian tubes 
(Bouckerchart, et al., 1986, and Bryans, et al., 1954). 
The peritoneal cavity of a female laboratory animal is 
preferred, such as a female mouse, it has been found that 
the peritoneal cavity of male laboratory animals can 
also be employed, although with somewhat less effec 
tive embryo development. 
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ILLUSTRATED EMBODIMENTS 
Several embodiment of the arti?cial zona pellucida 
assemblies of this invention are shown in the accompa 
nying drawings. FIG. 1 represents a tubular hydrogel 
cartridge which is provided with end closures in the 
form of removable end plugs. The hydrogel cartridge is 
prepared from a cross-linked hydrogel as described 
above. Illustrative dimensions of the hydrogel cartridge 
shown in FIG. 1 include a chamber length of 1 cm, an 
outside diameter of 3.5 mm, an inside diameter of 1.7 
mm, and a wall thickness of 0.9 mm. The wall thickness 
is given as 0.9 mm., but the wall thickness, as well as the 
other dimensions, may vary. Wall thicknesses within 
the range from 0.5 to 3 m can be used. The end plugs 
11 and 12 may be formed from a solid biocompatible 
polymer such as a silicone polymer. Alternatively, the 
end plugs may be formed of cross-linked HEMA, but 
transfer through the end plugs from the peritoneal or 
fallopian ?uid is not required. In FIG. 2, the arti?cial 
zona pellucida of FIG. 1 is shown in assembled condi 
tion, containing a nude blastomere 13 immersed in a 
suitable aqueous medium 14. 
In FIG. 3, there is shown, a multiple compartment 
arti?cial zona pellucida assembly 15. In this embodi 
_ ment, the ends of the hydrogel cartridge are slightly 
enlarged to receive the removable end plugs 16 and 17. 
Within the cartridge there is provided three spaced 
removable dividers 18, 19 and 20. These dividers may 
be formed of cross-linked HEMA, or a non-permeable 
biocompatible plastic may be employed as a silicone 
polymer. The dividers separate the cartridge chamber 
into four compartments, and within each compartment 
there is provided a nude blastomere. This assembly 
permits the simultaneous culturing of four blastomers 
21-24. Suitable aqueous media 25 will be employed 
within the compartments as previously described. 
For culturing the arti?cial zona pellucida assemblies, 
such as the assembly of FIG. 2 or FIG. 3, the peritoneal 
cavity of a mouse may be used. A mid-line incision may 
be made in the abdomen of the mouse, the assembly 
inserted, and the incision sutured. The inserted arti?cial 
zona pellucida assembly 15 will normally rest in the 
lower portion of the peritoneal cavity C of the mouse 
M, as illustrated in FIG. 4. Instead of a host mouse, 
other laboratory animals may be employed, including 
rabbits, guinea pigs, hamsters, etc. While contained in 
the laboratory animal, such as the preferred mouse, the 
zona pellucida assembly may be shipped to a detination. 
Within shipping times of 2 to 4 days, such as by air 
transport, the nude blastomeres can continue to develop 
to the blastocyst stage, and will be ready for implanta 
tion when the host mouse or other laboratory animal 
reaches its destination. 
The arti?cial zona pellucida of this invention may 
also be employed as an ova fertilization assembly 26, as 
illustrated in FIG. 5. The cConstruction of the hydrogel 
chamber and the end plugs is as previously described. A 
divider 27 is positioned centrally in the compartment. 
The divider may be formed from pHEMA or a silicone 
polymer, and is provided centrally with an opening of 
suf?cient size to permit sperm to pass therethrough. 
Ova culture medium is provided in the compartments. 
In the left-hand compartment 28 viable sperm is placed 
and in the right-hand compartment 29 an unfertilized 
ova 30. To facilitate capacitance of the sperm and 
thereby obtain fertilization, the assembly may be placed 
in the vagina of a host animal. After fertilization occurs, 
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the ova may be incubated in the cartridge until it is 
ready for implanting. Preferably on fertilization, the 
assembly is removed from the vagina and inserted in the 
peritoneal cavity or fallopian tube of the host animal. 
For embryo development, vaginal ?uid is not as effec 
tive as peritoneal or fallopian ?uid. 
FIG. 6 illustrates a further use of the assembly. With 
the construction of FIG. 1, the fertilized ova 31 is 
placed within the hydrogel cartridge 32 and is sur 
rounded with an aqueous ova culture medium 33. The 
assembly is then placed in the peritoneal cavity or fallo 
pian tube of the host animal and retained therein until 
the ova develops to the implant stage. 
The method of carrying out this invention and the 
results obtainable thereby are further illustrated by the 
following experimental examples. 
EXPERIMENTAL EXAMPLES 
Materials and Methods 
Construction of Hydrogel Chambers 
The hydrogel chambers were made from the mixture 
of HEMA monomer and tetraethylene glycol dimethac 
rylate (TGD) as the cross-linker. Ethylene glycol (DG) 
was used as a solvent. The formulation of reactants was 
that described by Lee et al. (1978, Table l) for a ratio of 
10 ml HEMA to 0.1 ml TGD. The mole % cross-linker 
in the hydrogel is approximately 0.4%. 
Before casting the chambers, 3 stock solutions were 
prepared and placed in glass test tubes: Solution A-a 
mixture of 10 ml HEMA, 0.1 ml TGD, 3.0 ml EG, and 
2.0 ml distilled water; solution B-initiator, 1.0 ml of 
ammonium persulfate, 40 g per 100 ml distilled water or 
1.75 M; solution B-c0-initiator, 1.0 ml of sodium meta 
bisulfite, 15 g per 100 ml distilled water or 0.79 M. Each 
stock solution was purged with nitrogen and the reac 
tants were mixed and polymerized under pressure, as 
described by Pinchuk et al. (1981) for the casting of 
ureteral anastomotic nipples. 
The hydrogel chambers were case at room tempera 
ture within the barrel of 71 mm long, 3.5 mm ID, 0.5 ml 
insulin syringes (No. 8471 single use, plastipak LO-dose 
U-l00; Becton Dickinson and Co., Rutherford, N.J.). 
The needle and its hub were removed to free the needed 
connector of the syringe. The plunger was withdrawn 
from the syringe and the rubber gasket at the tip of the 
plunger was removed and inverted so that the hollow 
cavity that previously attached the gasket to the 
plunger was directed toward the barrel of the syringe. 
The inverted gasket was then reinserted in the barrel 
and aligned with the SO-unit mark of the syringe. The 
syringe with the gasket in position was hand-held verti 
cally with the needle connector directed upwardly. The 
reactants, 1.51 ml of Solution A, 0.1 ml 0 Solution B, 
and 0.1 ml of Solution C were then mixed within a 3 ml 
polyethylene syringe just before loading the casting 
insulin syringes. The syringe containing the polymeriz 
ing mixture was ?tted with a ll inch (38.1 mm), 18 
gauge needle, which was passed through the connector 
to fill the barrel of the insulin syringe with 0.5 ml of the 
polymerizing mixture. Immediately after filling the cast 
ing syringe, a 5.6 cm long, 0.9 mm OD stainless steel 
rod, inserted into a 5.6-cm long, 1.7 mm OD Te?on 
tubing (Cole-Farmer International, Chicago, 111.) was 
passed through the needle connector and the mixture of 
reactants in the barrel of the insulin syringe to the rub 
ber gasket in order to form a hollow chamber in the 
polymerizing gel. The Te?on tubing with the inserted 
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steel rod was held in the center of the barrel by the 
needle connector and the hollow cavity of the inverted 
rubber gasket. A 6.0-cm long, 16 mm OD plexiglass rod, 
drilled through with a 7/32-inch bit (5.56 mm), was 
used to brace the barrel of the insulin syringe and pre 
vent breakage during pressurized polymerization. A 
4-cm long, 3.5 mm OD stainless steel rod was inserted 
into the ?anged end of the barrel of the syringe and used 
to apply pressure to the gasket and polymerizing mix 
ture. The braced syringe was then placed between size 
9 neoprene stoppers attached to the jaws of a pipe 
claimp. Pressure was applied for 15 minutes by closing 
the jaws of the clamp until all visible air bubbles were 
displaced from the polymerizing gel. No attempt was 
made to measure the pressure applied with the clamp. 
After this 15-minute period of perssurized polymeriza 
tion, the cast hydrogel was removed from the syringe 
and the centrally located Teflon tubing with the rod 
was withdrawn from the cast hydrogel which now was 
a hydrogel tube of approximately 5 cm long, with a 1.7 
mm lumen and 0.9 mm thick wall. The pHEMA hydro 
gel tubes, in batches of 10 tubes, were then placed for 96 
hours in a 100 ml glass beaker containing 95% ethanol 
which was changed every 12 hours to remove nonpoly 
merized HEMA. After ethanol washing, the pHEMA 
tubes were placed in a beaker containing 500 ml of 
distilled water, and heated at a slow boil for 4 hours. 
The distilled water was changed and the procedure 
repeated 12 times. After boiling, the pHEMA tubes 
were cut into 1 cm-long segments with a razor blade 
under observation with a stereoscopic microscope at 
10X. Segments containing visible ?aws were discarded. 
Solid plugs, 2 mm long were made from 0.085 inch (2.16 
mm) OD Silastic tubing (Dow Corning Corp., Medical 
Products Midland, Me.) ?lled with Silastic adhesive and 
used to close the ends of the pHEMA tube to form a 
chamber, as illustrated in FIGS. 1 and 2. Each l-cm 
segment of hydrogel tube and the 2 solid plugs to close 
the ends of the chamber were placed into a 2 ml glass 
ampulle (Wheaton Scienti?c, Millville, NJ.) containing 
distilled water. The ampulles were then autoclaved for 
40 minutes at 120° C., ?re-sealed, and stored at room 
temperature until used. 
Animals 
Twenty-three uniparous, crossbred rabbit does rang 
ing from 1.0 to 1.5 years of age were used as embryo 
donors or recipients for Experiments 1 and 2. Does 
were individually caged for at least 21 days before as 
signment to the experiments, fed commercial rabbit 
food, and maintained during the experimental period in 
a room with controlled temperature (20° to 22' C.) and 
light (12 hours’ light/l2 hours’ dark). Two crossbred, 
mature rabbit bucks of known fertility were individu 
ally caged, maintained in the same room, and fed, as 
described for the does. 
Fifteen mature, cycling female and 10 mature male 
Balb/c mice were used as intermediate recipients for the 
2 experiments of this study. Mice were caged by sex in 
groups of 4 to 5 females or 2 males per cage, fed com 
mercial mouse food, and maintained in a room with 
controlled temperature (20' to 22‘ C.) and light (14 
hours light/l0 hours dark). For the female mice inter 
mediate recipients, the stage of the estrous cycle was 
determined by vaginal smears and only females which 
were late in the afternoon of the day of estrus (D1) were 
used. 
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EXPERIMENT 1 
Transfer of Rabbit Embryos Cultured in pHEMA 
Hydrogel Chambers in the Peritoneal Cavity of 
Intermediate Mouse Recipients. 
Embryo Recovery and Culture 
Ten does were randomly selected from the 23 does to 
serve as embryo donors and 10 does were selected to 
serve as recipients. To induce superovulation, each 
donor doe was given a subcutaenous injection of 0.5 mg 
of follicle-stimulating hormone (FSH-P, Burns Biotec, 
Omaha, Nebr.) every 12 hours for 72 hours. Donor does 
were mated twice to each of the 2 bucks, 24 hours after 
the last FHS injection. Each of the 10 mated donors was 
then randomly paired with a recipient. To synchronize 
donors and recipients, each unmated recipient was in 
duced to ovulate by a single intramuscular injection of 
50 IU of human chorionic gonadotropin (hCG, Fort 
Dodge Laboratories, Ft. Dodge, Iowa), given 14 hours 
after the fourth mating of the corresponding paired 
donor. 
To recover l-cell rabbit embryos, does were anesthe 
tized with Halothane (Fort Dodge Laboratories, Ft. 
Dodge, Iowa) 18 hours after the 4th mating and each 
oviduct was flushed from the uterotubal junction with 3 
ml of 0.9% (or 0.154 M sodium chloride) sterile saline 
solution. After flushing and recovery, embryos were 
examined with an inverted microscope at 100 Xwhile 
still in the collecting dish and ?ushing ?uid. Oocytes 
that had spermatozoa in the perivitelline space or em 
bryos that had extruded the second polar body were 
considered to be l-cell embryos. The l-cell embryos 
from each doe were washed 3 times by trasnfer between 
10X 35 mm culture dishes (Lux, Miles Laboratories, 
Inc., Naperville, Ill.) containing sterile 0.9% saline solu 
tion before loading in the pHEMA hydrogel chambers. 
Three pHEMA hydrogel chambers were prepared 
for each doe before embryo collection. The sealed tip of 
each glass ampulle was broken and the tube and plugs 
were withdrawn with sterile forceps and placed in 
10x35 mm culture dishes containing sterile saline solu 
tion. With the aid of forceps, one of the solid plugs was 
inserted into one end of each of the 3 tubes and the tubes 
with the uninserted plugs were then incubated in a dish 
containing sterile saline solution for at least 110 minutes 
at 37° C., in an incubator with 5% CO2 in humidi?ed air, 
before loading the chamber with embryos. 
The l-cell embryos recovered from each donor doe 
were subdivided into 3 groups of equal numbers of 
embryos. The embryos from each group were trans 
ferred into the lumen of a saline solution-?lled pHEMA 
tube, while the tube was immersed in sale. (The saline 
was used instead of an embryo media to con?rm tran 
port from the peritoneal ?uid through the hydrogel.) 
The open end of the tube was then sealed with the 
second Silastic plug and the sealed chambers were ex 
amined at 20><with a stereoscopic microscope to verify 
the number of embryos and the integrity of the cham 
ber. The 3 chambers containing the embryos from each 
donor were then randomly assigned to one of the fol 
lowing treatment groups: Group 1: in vitro controls 
cultured for 72 hours in a 10X 35 mm culture dish con 
taining 3 ml of 0.9% sterile saline solution in an incuba 
tor at 37' C. with 5% CO2 in humidi?ed air; Group 2: 
cultured in vivo for 72 hours in the peritoneal cavity of 
an adult female Balb/c mouse on D1 of the cycle; 
Group 3: cultured in vivo for 72 hours in the peritoneal 
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cavit of an adult male Balb/c mouse. The embryo 
loaded chambers assigned to Groups 2 and 3 were surgi 
cally implanted in anesthetized (Metofane, Pitman 
Moore, Washington Crossing, NJ.) female or male 
mice through a l-cm long incision in the ventral abdom 
inal wall. After 72 hours of either in vitro or in vivo 
culture, the chambers were recovered and examined at 
25 to lOOXwith an inverted microscope to determine 
the stage of embryonic development. Embryos were 
classi?ed as follows: Embryos that did not cleave or had 
fragmented blastomeres were considered degenerated; 
embryos that cleaved beyond the l-cell stage, had rec 
ognizable, intact blastomeres, but did not reach the 
morula stage, were considered retarded; morulae were 
embryos that cleaved beyond the 16 cell stage but had 
not yet developed a blastocoele, while blastocysts were 
embryos with a clear, de?ned blastocoele. The number 
of degenerated or retarded embryos and the number of 
morulae and glastocysts obtained from each donor were 
recorded. 
Embryo Transfer. The morulae and blastocysts ob 
tained after in vivo culture in the pHEMA chambers 
were transferred to the paired recipient. Recipients 
were anesthetized with Halothane, as described for the 
donor does. The ventral area of the abdominal wall was 
clipped free of hair, disinfected, draped, and the uterine 
horns were exposed through a 6-cm long midventral 
incision. For each paired recipient, the left or right 
uterine horn was alternated as to receive embryos cul 
tured in vivo in either male or female mouse. Each horn 
was punctured with the eye of a No. 22 suture needle 
and the embryos from treatment groups 2 or 3 were 
transferred to the lumen of the assigned horn using a 5 
pl Wiretrol pipet (Fisher Scienti?c, Spring?eld, N.J.). 
The abdominal incision was sutured and each doe was 
?tted with an Elizabethan plastic collar until recovery 
from surgery. 
Twenty-one days after transfer, recipient does were 
laparotomized. Before laparotomy, each doe was se 
dated by an intramuscular injection of 1 mg per kg of 
body weight of Acepromazine (Ceva Laboratories, 
Inc., Overland Park, Kans.). The midventral abdominal 
area was disinfected and then in?ltrated with 10 mg/kg 
body weight of a 2% solution of Lidocaine (Astra Phar 
maceutical Products, Inc., Worcester, Mass). The uter 
ine horns were exposed and the number of fetuses 
within each horn was recorded. Fetuses from embryos 
cultured in male mice were marked in utero by an injec 
tion of l u of India ink deposited, as a subcutaneous 
drop, in the rump area of each fetus. At parturition, 
which occurred 6 to 8 days after laparotomy, the num 
ber of offspring derived from each of the 2 treatment 
groups was recorded. Bunnies were observed daily for 
general health until weaning. 
Experiment 2 
Blastomere Isolation and Culture in Compartmentalized 
pHEMA Hydrogel Chambers in the Peritoneal Cavity 
of Female Mouse Recipients. 
Four~cell rabbit embryos were recovered from the 3 
remaining does. Superovulation was induced and the 
embryos recovered, as described for Experiment 1, 
except that the oviducts were flushed 32 hours after the 
4th mating with Whitten 5 medium (WM, Whitten and 
Biggers, 1968) supplemented with 1 mg bovine serum 
albumin (BSA, Fraction V, Sigma Chemical Co., St. 
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Louis, Mo.) per ml of medium. The flushing medium 
was ?ltered through a 0.2 pm ?lter. 
To isolate blastomeres, the 4-cell embryos recovered 
from each doe were placed in 10X 35 mm culture dishes 
pretreated with Prosil 28 (PRC Inc., Gainesville, Fla.) 
to decrease adhesion of the blastomeres to the culture 
dish. The embryos were washed as a group 3 times at 
room temperature in ?ltered WV-BSA medium and 
then incubated for 15 minutes at 27' C. with 5% COzin 
humidi?ed air in Ca+ and MG++-free, modi?ed Dul 
becco’s phosphate buffered saline solution (DPBS, Dul 
becco and Bogt, 1954), supplemented with 0.02% (or 
0.68 mM) EDTA and 0.25 M glycerol. Next the em 
bryos were incubated for 15 minutes in modi?ed DPBS, 
supplemented with 0.50 M glycerol and then trans 
ferred to Prosil 28 treated culture dishes containing 
modi?ed DPBS supplemented with 1.0 M glycerol to 
remove the zona pellucida. The zona was removed 
under observation with inverted microscope at 
100x with a hand-held microknife made from a piece of 
razor blade. The zona-free blastomere clusters were 
then transferred and incubated 2 times for 15-minute 
periods, ?rst in a culture dish containing modi?ed 
DPBS supplemented with 0.50 M glycerol and then in 
modi?ed DPBS supplemented with 0.25 M glycerol. To 
separate the blastomeres, each blastomere cluster was 
transferred to a culture dish contianing modi?ed DPBS 
only and then subjected, during observation with a 
stereoscopic microscope at 20X, to repeated aspiration 
into and expulsion from a 50 um ID silicone coated 
capillary tube (Polymicro Technologies, Phoenix, 
Ariz.) attached to a 5 pl Wiretrol pipet. The isolated 
blastomeres were then washed 5 times by transfer be 
tween dishes containing WM-BSA medium. Only those 
embryos from each of the 3 donor does that yielded 4 
intact blastomeres were used in this experiment. Th 4 
blastomeres isolated from each embryo, hence a mono 
zygotic group, were placed within individual compart 
ments of a sterile pHEMA hydrogel chamber, under 
observation with a stereoscopic microscope at 20X. 
These chambers were made from HEMA, as described 
for Experiment 1, except that the length of each cham 
ber was increased to 2 cm in length. One of the open 
ends was sealed with a plug and the lumen of the cham 
ber was partitioned into 4 compartments, as illustrated 
in FIG. 3, by the insertion of 3, 1.7 mm OD><2 mm 
thick pHEMA discs, while in a 10X 35 mm culture dish 
containing WM-BSA medium. The WM-BSA in the 
compartments served as the initial blastomere culture 
medium. These discs were made from HEMA hydrogel 
polymerized at room temperature within a 1.7 ID Tef 
lon tubing without applying pressure. The ?rst blasto 
mere was placed in the chamber and one of the 
pHEMA discs was inserted in the lumen of the chamber 
and positioned at approximately 2.5 mm from the sealed 
end of the chamber. This procedure was repeated until 
each of the 4 blastomeres was loaded into the compart 
mentalized chamber, together with the WM-BSA me 
dium. The chamber was then sealed with the remaining 
plub, as shown in FIG. 3. The chambers containing 4 
isolated blastomeres were surgically implanted in the 
peritoneal cavity of a female Balb/c mouse on D1 and 
incubated in vivo for 72 hours as described for Experi 
ment 1. Because of the number of monozygotic groups 
obtained, 4 chambers were implanted in the peritoneal 
cavity of each of 5 female mice. At the end of the 72 
hour period of incubation, the compartmentalized 
chambers were recovered and the isolated blastomeres 
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were examined for development with an inverted mi 
croscope at 25 to 100x. 
Statistical Analysis 
End points for stage of development of embryos cul 
tured in vivo and for the results of transfer of morulae 
and blastocysts to recipient does between groups 2 and 
3 of Experiment 1 were compared by Chi-square analy 
sis, with 1 degree of freedom and Yates correction 
(Steel and Torrie, 1960). Signi?cance was established at 
P§0.05. Data for embryos cultured in vitro (control 
group 1 of Experiment 1) were not statistically com 
pared with those of groups 2 and 3 due to the 0 values 
obtained. ‘ 
RESULTS 
Experiment 1 
A total of 357, l-cell embryos recovered from 10 
donor does was used in this experiment (Table 1). all of 
the 238 embryos that were placed in the pHEMA cham 
bers and cultured in vivo in the peritoneal cavity of 
male or female mice were recovered at the end of the 72 
hours of in vivo culture, as reported in Table 1. All of 
the 119 embryos incubated in vitro in pHEMA cham 
bers had degenerated during the 72 hours of culture. In 
comparison, only 10.1% cultured in male mice and 
8.4% of the embryos cultured in female mice degener 
ated during the in vivo culture period. These differ 
ences were not signi?cant (P>0.05, Table 1). More 
(P<0.0005 Table 1) of the embryos cultured in female 
mice developed to blastocysts (68/119) than those cul 
tured in male mice (25/119). The transfer of 188 moru 
lae and blastocysts (Table 1) recovered from pHEMA 
chambers implanted in the peritoneal cavities of male 
and female mice resulted in 23 (12.2%) live offspring, as 
shown in Table 2. Fewer (P<0.005) offsprings were 
born from the transfer of embryos cultured in male mice 
(3/97, Table 2) than those cultured in female mice 
(20/ 81). Survival to term was not in?uenced (P>0.05) 
by the born to which embryos were transferred. The 23 
bunnies developed in an apparently normal fashion and 
were released for adoption after weaning. 
Experiment 2 
A total of 43, 4-cell embryos was collected from 3 
donor does and eighty intact blastomeres were isolated 
' from 20 of these 4-cell embryos. All of the blastomeres 
that were cultured in vivo were recovered from the 
compartmentalized pHEMA chambers after the 72 
hours of culture. Of these 80 isolated blastomeres, 16 
(20%) were retarded or degenerated, 21 (26%) devel 
oped to the morula and 43 (54%) to the blastocyst 
stages, as shown in Table 3. Eleven (44 blastomeres) of 
the 20 originally cultured monozygotic groups devel 
oped, apparently in synchrony, to become either moru 
lae or blastocysts. Including the 4 retarded blastomeres 
that cleaved but did not develop to the morula or blas 
tocyst stages, 85% (68/80, Table 3) of the isolated blas 
tomeres survived the isolation procedure and cleaved, 
while cultured in vivo in the compartmentalized 
pHEMA chambers. However, these de novo formed 
morulae and blastocysts were fragile and fragmented 
during withdrawal from the chamber. 
DISCUSSION 
In the present study, all of the embryos and blas 
tomeres cultured within pHEMA chambers were re 
covered following the 72 hours period of culture. The 
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development of l-cell rabbit embryos to the morulae 
and blastocyst stages within saline-?lled pHEMA 
chambers implanted in the peritoneal cavities of mice, 
as well as the birth of live offspring resulting from the 
transfer of these embryos, demonstrate that the 
pHEMA hydrogel chambers permit the passage of es 
sential factors from the peritoneal cavity into the lumen 
of the chamber, such that embryonic development 
could occur. These results also confirm that the perito 
neal cavity of mice can support the development of 
l-cell rabbit embryos to the blastocyst stage (see 
Briones, et al., 1954.) 
The percentage of l-cell rabbit embryos that devel 
oped to the morula and blastocyst stages during culture 
for 72 hours in the peritoneal cavity of female mice is 
comparable to that reported for 2- and 4-cel1 embryos 
cultured within the ligated oviducts of estrous does 
(Adams, 1973). The development of embryos cultured 
in male mice was retarded when compared to the devel 
opment of embryos cultured in female mice in our study 
or when compared to the rate of development in ligated 
oviducts (Adams, 1973). This suggests that the perito 
neal cavity of the male mouse is a less favorable envi 
ronment for embryonic development than that of the 
female mouse. . 
The percentage of offspring born from the transfer of 
morulae or blastocysts cultured from the l-cell stage in 
the peritoneal cavity of female mice (20/91, 22%) ap 
pears to be greater than that resulting from embryos 
cultured in vitro for 72 hours (7.0%, Adams, 1970, 14%, 
Maurer, 1978) and compares with the percentages re 
sulting from the transfer of 2 to 4-cell embryos cultured 
in the ligated oviduct of estrous does (17%, Adams, 
1973) or obtained after transfer of noncultured embryos 
to asynchronous recipients (27%, Yang, et al., 1986). 
The fewer offspring born from the transfer of l-cell 
rabbit embryos cultured in the peritoneal cavity of male 
mice (3/97, 3%) could be the result of the transfer of 
more morulae than blastocysts (72 morulae and 25 blas 
tocysts, Table 2) than for the female mice (23 morulae 
and 68 blastocysts). 
The number of isolated blastomeres that developed 
during in vivo culture to morulae and blastocysts, while 
contained in the compartmentalized pHEMA cham 
bers, as well as the recovery at the end of the incubation 
period of all of the resulting product of each of the 
isolated blastomeres, attest to the protective nature of 
the pHEMA chamber. The development of apparently 
normal blastocysts and the lack of trophoblastic vesicles 
in the blastocysts derived from isolated blastomeres 
suggests complete development while in the pHEMA 
chamber. 
In summary, the results of this study demonstrate that 
pHEMA hydrogel can be cast into scalable and easily 
retrievable chambers for the in vivo culture of embryos. 
TABLE 1 
Number of Embryos 
Treat- Re 
ment Cultured Degenerated tarded“ Morula Blastocyst 
In Vitro 119 119 0 0 0 
Controls 
Male 1 l9 12 10 72' 25 
Mouse 
Female 119 l0 18 23 68' 
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TABLE 1£ontinucd of the menstrual cycle. J. Reprod. Fen. 
T Nmnb" °;Embry°S Camous, et al., 1984. Cleavage beyond the block stage 
m2?‘ Cuhund Desmmd mid, MOM‘ Bhsmcyst and survival after transfer of early bovine embryos 
5 cultured with trophoblastic vesicles. J. Reprod. Fertil. 
“°“‘° 72:479-485. 
‘Embryosthatcleavedheyoodtbel-eellbutdidnotadvaneetothemorulastage. ‘ 
,5. .5 ?y a, < cm”) “at M the . in vivo mm‘ Eyestone, et al., 1985. Culture of l-cell boveln embryos 
group. in the sheep oviduct. Proc. 18th Ann. Meeting Soc. 
Study Reprod., Montreal, Canada, Jul. 22-25, 1985, 
TABLE 2 
Sex of 
Recipient intermedla' te Number (stage)' Uterine Fetuses Offspring 
number mouse recipient transferred horn day 25" born alive 
1 male 7 (M), 3 (B) left 0 — 
female 1 (M), 9 (B) right 0 — 
2 male a (M), 4 (B) right 0 - 
female 11 (B) left 3 3 
3 male 6 (M), 2 (B) left 0 - 
female 9 (B) right 3 3 
4 male 10 (M), 1 (a) right 0 - 
female 13 (B) left 4 4 
5 male 7 (M), l (B) left 0 - 
female 7 (M) right 0 — 
6 male 7 (M), 2 (B) right 0 — 
female 1 (M), 7 (B) left 2 2 
7 male 11 (M), 2 (B) left 1 1 
female 3 (M), 9 (B) right 4 4 
8 male 5 (M), 5 (B) right 2 2 
female 9 (B) left 4 4 
9 male 7 (M), 1 (B) left 0 - 
female 6 (M) right 0 — 
10 male 4 (M), 4 (B) right 0 - 
_ female 5 (M), l (B) left 0 — 
Totals male 97 (72M), (25B) - 3 3 
female 91 (23M), (68B) - 20 20 
‘Stage: 
00- momla: 
(B), blastocyst. 
"Determined by laparotomy on day 25 of gestation. 
, TABLE 3 Abstract 125. 
2x251,” mm“ md culmmd 80 Fisher, 1987. Development retardation in cultured 
Degenm‘t'u} 12 40 preimplantation rabbit embryos. J. Reprod. Fertil. 
Retarded“ 4 79:115-123. 
Mmul" 21 Lee et a1. 1978 Solute transport through crosslinked 
gmfg'csgmd m" culture 23 poly (Z-hydroxyethyl methacrylate) membrane. J. 
Total developing to the morula or blastocysts stages 64 [1 l] Bloeng" 2:269-278- _ _ 
'Blastomeres that cleaved but did not advance to the morula or blastocyst stages. 45 Maure? Advances m rabbn' cultlue‘ In: 
[1 Brackets indicate monozygotic groups. Damel, J. G., Jr. (ed.), Methods 111 MAmmallan Re 
production. New York: Academic Press, pp. 
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We claim: 
1. An arti?cal zona pellucida assembly suitable for 
implantation in the peritoneal cavity of a small labora 
tory animal, said assembly comprising a hollow car 
tridge of a size suitable for implantation in said perito 
neal cavity said cartridge providing an enclosed incuba 
tion chamber and having a chamber-enclosing wall 
formed of cross-linked microporous hydrogel, at least 
one nude isolated mammalian blastomere of a species 
different than the laboratory animal contained within 
said chamber, and an aqueous culture medium in said 
chamber in contact with said blastomere and the inside 
of said hydrogel wall. 
2. The assembly of claim 1 in which said cartridge is 
tubular with open ends, and closure lugs are removably 
received in said ends. 
3. The assembly of claim 1 or claim 2 in which said 
incubation chamber has at least one removable divider 
arranged to subdivide said chamber into a plurality of 
separate incubation compartments, and at least one of 
said blastomeres is contained within each of said com 
partments. 
4. The assembly of claim 1 or claim 2 in which said 
hydrogel wall is formed from polymerized cross-linked 
2-hydroxyethyl methacrylate (HEMA), which hydro 
gel contains not over 2.5 moles percent of cross-linker. 
5. An arti?cial zona pellucida assembly suitable for 
implantation in the peritoneal cavity of a small labora 
tory animal said assembly comprising a tube of a size 
suitable for implantation in said peritoneal cavity, re 
movable end plugs for said tube to provide an enclosed 
incubation chamber, said tube being formed of cross 
linked microporous hydrogel which under the condi 
tions of use is non-biodegradeable, at least one viable 
nude isolated mammalian blastomere of a species differ 
ent than the laboratory animal contained within said 
chamber, and a culture medium in said chamber in 
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contact with said blastomere and the inside of said hy 
drogel tube. 
6. The assembly of claim 5 in which said tube has a 
wall thickness of from 0.5 to 3 millimeters (mm). 
7. The assembly of claim 5 or claim 6 in which said 
hydrogen is formed from polymerized cross-linked 2 
hydroxyethyl methacrylate (HEMA) and which hydro 
gel contains from 0.2 to 1.0 mole percent of cross-linker. 
8. The combination of claim 5 or claim 6 in which 
said tube is formed from polymerized cross-linked 2 
hydroxyethyl methacrylate (HEMA) which is cross 
linked with a glycol dimethacrylate selected from the 
group consisting of ethylene glycol dimethacrylate and 
tetraethylene glycol dimethacrylate, said cross-linked 
hydrogel containing from 0.2 to 1.0 mole percent of said 
cross-linker. 
9. An arti?cial zona pellucida assembly suitable for 
implantation in the peritoneal cavity of a small labora 
tory animal said assembly comprising a hollow car 
tridge of a size suitable for implementation in said peri 
toneal cavity, said cartridge providing an enclosed incu 
bation chamber and having a chamber-enclosing wall 
formed of cross-linked microporous hydrogen, said 
hydrogel being composed of polymerized Z-hydrox 
yethyl methacrylate (HEMA) cross-linked with a gycol 
dimethacrylate selected from the group consisting of 
ethylene glycol dimethacrylate and tetraethylene gly 
col dimethacrylate, at least one viable nude isolated 
mammalian blastomers of a species different than the 
laboratory animal removably contained within said 
chamber, and an blastomers culture medium in said 
chamber in contact with said blastomers and the inside 
of said hydrogel wall. 
10. The assembly of claim 9 in which said hydrogel 
wall has a thickness of from 0.5 to 3 millimeters (mm), 
and said cross-linker is present in said hydrogel in an 
amount of 0.1 to 2.5 mole percent. 
11. The assembly of claim 9 or claim 10 in which said 
cross-linker is present in said hydrogen in an amount of 
from 0.2 to 1.0 mole percent. 
12. The assembly of claims 1, 5, or 9 in which said 
small laboratory animal is a mouse. 
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